Full-Time

Director of Commercial Marketing

Mendaera

Mendaera

51-200 employees

Delivers point-of-care medical devices

Compensation Overview

$190k - $219k/yr

San Mateo, CA, USA

In Person

Willing to travel up to 30% for customer visits, conferences, and training.

Bachelor's, MBA

Category
Growth & Marketing (1)

Get referred to Mendaera

See people who can refer or advise you

Requirements
  • Bachelor’s degree; MBA or advanced degree preferred.
  • 7+ years of progressive clinical or commercial marketing experience in medical devices, robotics, or capital equipment, with demonstrated success in procedure/specialty-specific commercialization.
  • Minimum 5 years of surgeon-facing clinical marketing with a track record of driving procedure adoption and utilization growth in a therapeutic medical device or surgical robotics company. Direct OR experience strongly preferred.
  • Proven capability in KOL development, clinical society engagement, market development, and health economics—along with demonstrated experience in customer segmentation, persona development, and voice-of-customer (VOC) programs that inform strategy and content.
  • Analytical and strategic thinker with strong executive presence; ability to influence cross-functional stakeholders and communicate compellingly to clinical, administrative, and executive audiences.
  • Willingness to travel (30%) for customer visits, conferences, case observations, and institutional engagement.
Responsibilities
  • Lead commercial marketing efforts to sell the Focalist platform into hospitals and health systems, working closely with Sales leadership.
  • Develop value propositions tailored to hospital administrators, service line leaders, and economic buyers—highlighting ROI, efficiency gains, and clinical differentiation.
  • Support the sales process with hospital-facing presentations, negotiation frameworks, and competitive positioning tools.
  • Develop and continuously refine clinical value propositions for each procedure and specialty Focalist competes in—grounded in procedure-level insights and translated into messaging that drives adoption and utilization across physician, care team, and hospital audiences.
  • Develop and execute specialty-level market development programs—peer-to-peer events, case observation programs, symposia, and conference presence—designed to build procedural competency and expand the base of trained, active Focalist users.
  • Serve as the internal clinical marketing authority for each specialty—translating field feedback, surgeon insights, and competitive intelligence into updated messaging, tools, and programs that keep the commercial org aligned and focused. Champion voice-of-customer (VOC) initiatives to ensure continuous input from clinicians and care teams informs strategy, content, and program design.
  • Build a layered KOL network spanning Speaker/Reference KOLs, Teacher/Proctor KOLs, and Society/Executive KOLs—developing each tier’s ability to present, teach, and champion Focalist procedures.
  • Engage with clinical societies, guideline committees, and academic programs to elevate awareness and credibility.
  • Partner with Clinical Affairs and Medical Affairs to develop and execute a publication strategy supporting procedure adoption goals—including outcomes data, case series, and health economics evidence.
  • Partner with KOLs to develop and deliver high-impact podium presentations across virtual and in-person formats—including society symposia, peer-to-peer programs, proctored case observations, and conference abstracts.
  • Support KOLs in translating clinical experience with Focalist into compelling narratives for surgeon and care team audiences.
  • Create impactful marketing assets: case studies, procedure videos, brochures, and value stories that quantify clinical, economic, and strategic impact for physicians and hospital decision-makers.
  • Build and maintain ROI models, cost-effectiveness tools, and health economics evidence that support hospital and payer conversations.
  • Partner with Sales to deliver enablement tools: pitch decks, objection handling guides, competitive positioning, and training kits.
  • Produce thought-leadership content including white papers, KOL testimonials, and conference abstracts that bring Focalist’s value story to life.
  • Ensure all materials reflect Mendaera’s human-centered mission and resonate with physicians, administrators, and healthcare systems.
  • Align with Product, Clinical Affairs, Regulatory, Sales, and Marketing Communications to deliver cohesive commercialization strategies.
  • Serve as the primary commercial marketing partner to both capital and clinical sales teams, providing tools, messaging, and programs that drive system placement and procedure utilization.
  • Provide briefings to Mendaera Sr. Staff as needed.
  • Lead early adopter programs, pilot launches, and reference site development to measure outcomes, adoption, and workflow impact—building a replicable model for national scale.
  • Build marketing capabilities to measure clinical program impact, track procedure-level KPIs, and enable real-time tactical adjustments. Communicate findings and strategic implications to Sr. Staff.
  • Build and lead a high-performing clinical marketing team over time—fostering capabilities across specialty marketing, hospital audience engagement, and clinical evidence development.
  • Champion a culture of accountability, customer insight, and commercial impact.
  • Foster collaboration, innovation, and accountability across functions.
Desired Qualifications
  • Direct experience in procedural robotics, capital equipment, or minimally invasive surgical technology.
  • Familiarity with image-guided procedures, ultrasound, and interventional or procedural specialties (urology, IR, transplant, emergency medicine, or regional anesthesia).
  • Prior leadership of clinical pilots, early adopter programs, or reference site development—including measurement of outcomes, workflow impact, and replication strategies.

Mendaera provides medical devices and healthcare technology designed to support clinicians at the point of care. Its solutions help doctors and nurses perform procedures with higher precision and consistency directly where patients receive treatment, aiming to streamline care and improve outcomes. The devices integrate into the care workflow to reduce unnecessary patient movement, speed recovery, and lower overall costs. Revenue comes from selling these technologies to hospitals, clinics, and individual practitioners, with engagement also involving administrators and payors to align value and reimbursement. The company adheres to regulatory standards to ensure safety and effectiveness, partnering with regulators and stakeholders to bring compliant technologies to market. Overall, Mendaera’s goal is to improve patient outcomes, boost patient satisfaction, and reduce the cost of care by making medical interventions more efficient at the point of care.

Company Size

51-200

Company Stage

Series B

Total Funding

$97M

Headquarters

San Carlos, California

Founded

2020

Get referred to Mendaera

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA cleared Mendaera Guidance System on July 2, 2025, de-risking commercialization.
  • Cook Medical collaboration and EchoNous partnership expand distribution and instrumentation options.
  • January 2025 CCO hire and Avail telepresence acquisition support sales and remote care.

What critics are saying

  • Focalist remains pre-commercial; full commercialization is expected in 2026.
  • Olympus, Intuitive, and Butterfly Network target adjacent ultrasound-guided procedure workflows.
  • Clinical adoption stalls if PCNL and needle procedures disappoint after July 2025 launch.

What makes Mendaera unique

  • Focalist cleared July 2, 2025, combines handheld robotics with real-time ultrasound guidance.
  • Cook Medical and EchoNous integrate Mendaera into needle-based workflows across urology.
  • Fred Moll-backed team brings Auris and Intuitive execution experience to market entry.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

3%

2 year growth

1%
Archyde
Jul 8th, 2025
Mendaera Secures $73M to Revolutionize Robotics

Mendaera, a healthcare robotics firm, secured $73 million in Series B funding, following a $24 million Series A led by Lux Capital in 2023. The funds will help scale their robotic and AI technologies for medical procedures like biopsies and organ access. Mendaera is expanding partnerships, including with Cook Medical and EchoNous, to enhance needle-based interventions. They also acquired Avail Medsystems' telepresence tech to improve patient access and care delivery.

Bioscience Association Manitoba
Apr 28th, 2025
Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics

Cook Medical collaborates with Mendaera(TM) to advance needle-based intervention with handheld robotics.

BioSpace
Jan 9th, 2025
Mendaera Appoints Medical Robotics Leader Eric Davidson as Chief Commercial Officer

Mendaera appoints medical robotics leader Eric Davidson as Chief Commercial Officer.

Yunpai Sheji
Nov 13th, 2024
Mendaera raises $73M for robotics system

Mendaera has secured $73M in venture capital to advance its handheld robotics platform for needle-based procedures like biopsy and vascular access. The Silicon Valley startup aims to address healthcare provider shortages and rising demand by integrating real-time imaging with robotic guidance. The Series B funding was led by Threshold Ventures, with participation from Lux Capital and others, to enhance patient care and expand access to high-quality medical procedures.

AuntMinnie.com
Oct 8th, 2024
EchoNous partners with Mendaera

Portable ultrasound company EchoNous and AI and robotics company Mendaera have established a commercial partnership to develop new ultrasound-guided technology for interventional procedures.